Paris - Delayed Quote EUR
Nicox S.A. (ALCOX.PA)
As of 3:18 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
--
-23,125.0000
-18,481.0000
-5,392.0000
-16,051.0000
Investing Cash Flow
--
132.0000
-175.0000
4,949.0000
-95.0000
Financing Cash Flow
--
8,643.0000
13,409.0000
19,584.0000
22,183.0000
End Cash Position
--
27,650.0000
41,970.0000
47,195.0000
28,102.0000
Capital Expenditure
--
-42.0000
-8.0000
-20.0000
-95.0000
Issuance of Capital Stock
--
218.0000
91.0000
--
--
Issuance of Debt
--
8,964.0000
13,713.0000
20,597.0000
22,379.0000
Repayment of Debt
--
-165.0000
--
--
--
Repurchase of Capital Stock
--
--
--
-633.0000
--
Free Cash Flow
--
-23,167.0000
-18,489.0000
-5,412.0000
-16,146.0000
12/31/2019 - 4/12/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ITH.F Nektar Therapeutics
1.2490
-1.81%
APH0.F Ampio Pharmaceuticals, Inc.
3.6200
0.00%
ALOPM.PA Oncodesign Precision Medicine Société anonyme
1.0600
-2.75%
GXE.BE Galapagos NV
25.26
-0.79%
ALINT.PA IntegraGen SA
0.5050
+1.00%
ALVIO.PA Valerio Therapeutics Société anonyme
0.0805
0.00%
ALVAL.PA Valbiotis SA
1.1880
-1.00%
AREC.L Arecor Therapeutics plc
75.00
0.00%
AVCTF Avacta Group Plc
0.6524
0.00%
BETRF BetterLife Pharma Inc.
0.0800
0.00%